跳至主要内容
临床试验/NCT03982238
NCT03982238已完成4 期

Effects of Continuous Subcutaneous Insulin Infusion and Oral Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

Majianhua1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2019年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
74
试验地点
1
主要终点
total testosterone levels

研究概览

简要总结

The study will assess the total testosterone and sex hormone-binding globulin levels in men with type 2 diabetes before and after continuous subcutaneous insulin infusion and hypoglycemic drugs treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • volunteer to participate and be able to sign informed consent prior to the trial.
  • patients with type 2 diabetes, aged 18-60 years old, meeting WHO1999 diagnostic criteria, have not used any hypoglycemic drugs.
  • HbA1c > 9%.
  • subjects are able and willing to eat and exercise regularly.

排除标准

  • patients with insulin allergy.
  • impaired liver and kidney function with ALT 2.5 times higher than the upper limit of normal value;Serum creatinine was 1.3 times higher than the upper limit of normal.● drug abuse and alcohol dependence in the past 5 years.
  • systemic hormone therapy was used in the last three months.
  • patients with poor compliance and irregular diet and exercise.
  • patients with infection and stress within 4 weeks.
  • any other obvious conditions or associated diseases determined by the researcher: such as severe cardiopulmonary diseases, endocrine diseases, neurological diseases, tumors and other diseases, other pancreatic diseases, history of mental diseases.

研究组 & 干预措施

Control group

Active Comparator

continuous subcutaneous insulin infusion therapy

干预措施: Insulin (Drug)

Metformin

Experimental

metformin therapy

干预措施: Metformin (Drug)

Dapagliflozin

Experimental

Dapagliflozin

干预措施: Dapagliflozin (Drug)

结局指标

主要结局

total testosterone levels

时间窗: 1 month

changes of total testosterone levels

次要结局

  • bioavailable testosterone(1 month)
  • free testosterone(1 month)

研究者

发起方
Majianhua
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Majianhua

Director, Head of Endocrinology department, Clinical Professor

Nanjing First Hospital, Nanjing Medical University

研究点 (1)

Loading locations...

相似试验